Meds Marketing Portal

Terms of service

Effective October 9, 2026. These terms govern your use of Meds Marketing Portal, a workspace for creative production, creator submissions, and delivery review.

Access and authorized use

Use the portal only for work you are authorized to perform. Keep your account and invitation links secure, provide accurate information, and notify us if you suspect unauthorized access. Google sign-in identifies your account; it does not guarantee permission to enter the workspace.

Your content

Submit only content that you have the right to provide and that is appropriate for the assigned production workflow. You authorize the processing, storage, review, and transfer of submitted content needed to carry out that workflow. Ownership, licensing, payment, delivery requirements, and other commercial obligations remain governed by your separate agreements with Meds Marketing or the relevant commissioning party.

Connected services

Optional integrations operate within the permissions you grant and are also subject to the relevant provider’s terms. You may revoke those permissions. Automated matches, transcripts, analysis, and drafts may contain errors; review them before relying on them or taking external action.

Acceptable use

Do not misuse another person’s account or data, upload unlawful or malicious material, infringe intellectual-property or privacy rights, bypass access controls, or interfere with the service. Access may be restricted or suspended to address misuse, security concerns, or the end of your authorized engagement.

Privacy and availability

Our privacy policy explains how information is handled. The portal may change or be unavailable during maintenance, provider outages, or other interruptions. These terms do not replace a signed agreement governing your work or limit rights that cannot lawfully be limited.

Contact and updates

For access, support, or questions about these terms, email matthew@bluechew.com. Updated terms will be posted here with a revised effective date.